Page 16 - Orchid Essentials News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Eybna Announces Q3 Partnerships with Legacy Brands, Fueling National Expansion
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Eybna Announces Q3 Partnerships with Legacy Brands, Fueling National Expansion
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Orchid Ventures, Inc.: Orchid Ventures Announces Financial Results for Period Ended March 31, 2021
/ ORCHID VENTURES, INC. (CSE:ORCD; OTC:ORVRD) (the
Company or
Orchid ) is pleased to announce its third quarter ( Q3 2021 ) financial results for the period ended March 31, 2021. All amounts expressed are in United States dollars.
Nine Months Ended March 31, 2021
Nine Months Ended March 31, 2020
Variance
$(994,357)
-77%
Financial statements are prepared in accordance with International Financial Reporting Standards (IFRS). Detailed information regarding the Company s financial results as well as management s discussion and analysis can be found on its SEDAR profile at https://sedar.com/ and https://ir.orchidessentials.com/.
Management Commentary
Orchid Ventures Announces Financial Results for Period Ended March 31, 2021
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
On Monday,
Tilray, Inc. (NASDAQ:TLRY) and
Aphria, Inc. (NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion. Benzinga spoke with
Irwin Simon, CEO of the new combined company.
Check out the video below:
Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23.
Jazz Pharmaceuticals (NASDAQ:JAZZ) finalized its acquisition of
GW Pharmaceuticals plc. (NASDAQ:GWPH), the producer of the FDA‑approved prescription cannabidiol drug Epidiolex, for $7.2 billion or $6.7 billion net of GW Pharma s cash.
Meanwhile,
Ascend Wellness Holdings (CSE:AAWH) started trading on the Canadian Securities exchange following a raise of approximately $80 million through an initial public offering of roughly 10 million shares of its Class A common stock at $8 per share.